VIR - Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03 revenue of $2.6M misses by $6.17M
2023-11-02 16:33:24 ET
More on Vir Biotechnology
- Vir Biotechnology: A Beaten Up Biotech With A Large Margin Of Safety
- Vir Biotechnology: Strong Balance Sheet But Commercial Prospects Await Further Clarity
- Vir Biotechnology, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Vir Biotechnology Q3 2023 Earnings Preview
- Vir Biotech nabs $50M BARDA funding to discover antibody therapies
For further details see:
Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03, revenue of $2.6M misses by $6.17M